Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Clinical Diagnostics), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Clinical Diagnostics), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3704 | Pages: 145 | October 2017 | Region: Asia Pacific


The Asia Pacific Radioimmunoassay Market was worth USD 66.42 million in 2016 and estimated to be growing at a CAGR of 4.2%, to reach USD 81.59 million by 2021. Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in the blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody-antigen binding and their quantitation by using radioactivity.

Radioimmunoassay is used primarily in the healthcare industry due to its high sensitivity, which can be used to analyze nanomolar and picomolar concentrations of hormones in biological fluids. RIA has ever since becoming one of the major tools in various clinical laboratories for diagnostic procedures, such as assessing the plasma levels of most of the hormones, identifying the presence of certain abused drugs, checking for the presence of hepatitis B surface antigen in donated blood, and other similar applications. This technique has also proven to be useful in the early detection of cancer, treatment of peptic ulcers, research with neurotransmitters, detection of infections, and identification of allergens in food and house dust, and more applications for the same are being researched all the time.

The major factors affecting the Asia Pacific Radioimmunoassay Market include the high investment, the increasing emphasis on R&D in the sector, technological advancements, their increased usage in pharmaceutical industries, research, rising need for quality and error-free diagnosis and consumer awareness. However, in spite of the drivers, the market remains restrained by the high costs associated with its usage, and the stern regulatory restriction and expertise required for the analysis.

The Asia Pacific Radioimmunoassay Market is broadly classified into Reagents and Kits Market and Analyzers Market based on type, based on End User into Hospital, Pharmaceutical Industry and CRO, Academics and Clinical Diagnostic Laboratories, on the basis of Application into Research and Clinical Diagnostics. Based on geography, the Asia-Pacific market is divided into India, China, South Korea, Japan and Australia. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. In addition to having the highest growth rate, the region also has the third highest market share. The rapid growth of the region can be attributed to the developing stature of countries such as India and China.

The Asia Pacific Radioimmunoassay Market is highly competitive with a large number of players. Key market players dominating the market with their products and services are DIAsource ImmunoAssays SA, Beckman Coulter, Inc, IBL International, PerkinElmer, Inc., DRG International, Inc., MP Biomedicals, LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A.., EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  2. Asia Pacific Reagents and Kits Market By Region, From 2016-2021 ( USD Million )
  3. Asia Pacific Analyzers Market By Region, From 2016-2021 ( USD Million )
  4. Asia Pacific Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  5. Asia Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  6. Asia Pacific Pharmaceutical Industry and CRO Market By Region, From 2016-2021 ( USD Million )
  7. Asia Pacific Academics Market By Region, From 2016-2021 ( USD Million )
  8. Asia Pacific Clinical Diagnostic Laboratories Market By Region, From 2016-2021 ( USD Million )
  9. Asia Pacific Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
  10. Asia Pacific Research Market By Region, From 2016-2021 ( USD Million )
  11. Asia Pacific Clinical Diagnostics Market By Region, From 2016-2021 ( USD Million )
  12. Japan Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  13. Japan Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  14. Japan Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
  15. China Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  16. China Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  17. China Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
  18. India Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  19. India Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  20. India Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
  21. Australia Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  22. Australia Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  23. Australia Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
  24. South Korea Radioimmunoassay Market By Type, From 2016-2021 ( USD Million )
  25. South Korea Radioimmunoassay Market By End User, From 2016-2021 ( USD Million )
  26. South Korea Radioimmunoassay Market By Application, From 2016-2021 ( USD Million )
Middle East And Africa Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrum...
Latin America Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrument), End...
Asia Pacific Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrument), End ...
Europe Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrument), End User (...
North America Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrument), End...
Surface Disinfectant Market By Formulation (Wipe, Liquid, Spray), By Type (Quaternary Ammonium Compounds, Phenol, Chlorhexidine Gluconate, Alcohol, Aldehyde), By Application (In-house, Instrument), End User (Hospita...
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.